Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 7 Colorectal Neoplasms 7 Neoplasms 6 Breast Neoplasms 6 Lung Neoplasms 4 Uterine Cervical Dysplasia 2 Prostatic Neoplasms 2 Papillomavirus Infections 2 End Stage Liver Disease 2 Warts 1 Urinary Bladder Neoplasms 1 Tinea 1 Smoking 1 Skin Neoplasms 1 Pancreatic Neoplasms 1 Nevus 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Molluscum Contagiosum 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lung Cancer Screening 1 Liver Neoplasms 1 Kidney Failure, Chronic 1 Keratosis, Actinic 1 Intestinal Neoplasms 1 Impetigo 1 Herpes Zoster 1 Hepatitis C 1 Heart Diseases 1

Interventions

Therapeutics 29 Psychiatric Rehabilitation 20 Cognitive Behavioral Therapy 12 Early Intervention, Educational 10 Psilocybin 9 Ketamine 9 Methods 8 Saline Solution 7 Yoga 6 Surveys and Questionnaires 6 Mindfulness-Based Cognitive Therapy 6 Esketamine 6 Counseling 6 Psychosocial Intervention 5 Mindfulness 5 Methylphenidate 5 Educational Status 5 Behavior Therapy 5 Acupuncture Therapy 5 Interviews as Topic 4 Exercise Therapy 4 Exercise 4 Escitalopram 4 Control Groups 4 Caregivers 4 Psychotherapy 3 Palliative Care 3 Niacin 3 Mindfulness-Based Stress Reduction 3 Melatonin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Depression × Mass Screening × Clear all

NCT02273206 2020-03-12

PCM3

Clinical Directors Network

Phase NA Completed

802 enrolled 28 charts

Depression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡